Your browser doesn't support javascript.
loading
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy.
Das, Satya; Ciombor, Kristen K; Haraldsdottir, Sigurdis; Pumpalova, Yoanna; Sahin, Ibrahim H; Pineda, G; Shyr, Yu; Lin, E P; Hsu, Chih-Yuan; Chu, Shih-Kai; Goff, Laura W; Cardin, Dana B; Bilen, Mehmet A; Fisher, George A; Wu, Christina; Berlin, Jordan.
Afiliação
  • Das S; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Ciombor KK; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Haraldsdottir S; Divisions of Medical Oncology, Department of Medicine, Stanford University Medical Center, Stanford, California, USA.
  • Pumpalova Y; Division of Hospital Medicine, Department of Medicine, Stanford University Medical Center, Stanford, California, USA.
  • Sahin IH; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.
  • Pineda G; Divisions of Medical Oncology, Department of Medicine, Stanford University Medical Center, Stanford, California, USA.
  • Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Lin EP; Department of Biostatistics, Vanderbilt University Medical Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Hsu CY; Big Data Research Center, Fu Jen Catholic University, Taipei, Taiwan.
  • Chu SK; Department of Biostatistics, Vanderbilt University Medical Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Goff LW; Department of Biostatistics, Vanderbilt University Medical Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Cardin DB; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Bilen MA; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Fisher GA; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.
  • Wu C; Divisions of Medical Oncology, Department of Medicine, Stanford University Medical Center, Stanford, California, USA.
  • Berlin J; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.
Oncologist ; 25(8): 669-679, 2020 08.
Article em En | MEDLINE | ID: mdl-31943525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article